Navigation Links
Sanford-Burnham researchers find molecular switch that allows melanoma to resist therapy
Date:2/2/2012

LA JOLLA, Calif. -- The National Cancer Institute (NCI) estimates that as many as one in 51 men and women will be diagnosed with melanomathe deadliest form of skin cancerat some point during their lifetimes. A research team led by Ze'ev Ronai, Ph.D. at Sanford-Burnham Medical Research Institute (Sanford-Burnham) is working to unravel the molecular mechanisms underlying the development and progression of this disease in hopes of improving prevention and treatment strategies. To do this, Ronai's laboratory has been studying a protein named Activating Transcription Factor 2 (ATF2), which is associated with poor prognosis in melanoma. ATF2 is a two-faced proteinin melanoma cells, it's oncogenic, or cancer-causing, while in non-malignant types of skin cancers, it acts as a tumor suppressor. In a paper published February 3 in the journal Cell, the team identified a molecular switch that controls ATF2's dual functions. This switch is controlled by protein kinase Cε (PKCε), which disables ATF2's tumor-suppressing activities, sensitizing cells to chemotherapy; instead, ATF2's tumor-promoting activity is enhanced. The team also found that high levels of PKCε in melanoma are associated with poor prognosis.

"PKCε is the culprit behind melanoma's 'oncogenic addiction,'" said Ronai, associate director of the Sanford-Burnham's NCI-designated Cancer Center and senior author of the study. "ATF2 is normally a 'good guy.' But when there is too much PKCεas in malignant melanomaATF2 becomes an oncogene, promoting tumor development."

In this study, Ronai and lead author Eric Lau, Ph.D., a postdoctoral researcher in his lab, found that PKCε's malignant power is in its ability to direct ATF2's location and activity within a cell. In a normal cell, PKCε modifies ATF2, keeping it in the nucleus, where it turns genes on and off and helps repair damaged DNA. When the cell experiences exposure to toxicity or stress (radiation,
'/>"/>

Contact: Heather Buschman, Ph.D.
hbuschman@sanfordburnham.org
858-795-5343
Sanford-Burnham Medical Research Institute
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Scripps Health and Sanford-Burnham to collaborate to advance new cancer treatments
2. Dr. Kristiina Vuori Promoted to President of Sanford-Burnham Medical Research Institute
3. Dana-Farber and Sanford-Burnham Institute license flu-targeting antibodies to Genentech and Roche
4. Researchers Spot Potential Bile Duct Cancer Drug Targets
5. Georgetown Lombardi researchers present new findings on head & neck cancers
6. Researchers discover method to unravel malarias genetic secrets
7. Researchers quantify muscle soreness
8. Georgetown professor applauds decision of researchers to temporarily halt research on H5N1
9. Health benefits of exercise may depend on cellular degradation, UT Southwestern researchers report
10. Autism redefined: Yale researchers study impact of proposed diagnostic criteria
11. University of Tennessee researchers develop comprehensive, accessible vision testing device
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Sanford-Burnham researchers find molecular switch that allows melanoma to resist therapy
(Date:6/2/2015)... June 02, 2015 TheCelebrityDresses.com, a popular ... big discounts on their summer fashion cocktail dresses. The ... short dresses that would be suitable for a wide ... , TheCelebrityDresses.com designs and make high quality trendy ... they use include high quality satin, chiffon and cotton. ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 The ... a study from the RSSearch® Patient Registry evaluating ... body radiotherapy (SBRT) for the treatment of centrally ... lung metastases. , The study, published in ... http://www.ro-journal.com/content/10/1/113/abstract ), included 111 patients with 114 centrally ...
(Date:6/2/2015)... Robert LaPrade, MD, PhD, Colorado Knee ... Research Institute, participated in the study “ When ... This was a collaborative project from the American Orthopaedic ... recently published in the American Journal of Sports Medicine. ... is evidence that early sport specialization may put young ...
(Date:6/2/2015)... Each year, Cosmetic Executive Women (CEW) awards ... year, the organization’s members – 8,000 industry experts – ... Beauty Quest Award at the 2015 Beauty Insiders’ Choice ... and 2-in-1 approach to skincare differentiated it amongst a ... consumer and professional fan bases, QVC has awarded Scalisi ...
(Date:6/2/2015)... 2015 SB 277 (CA Legislature, bit.ly/1Q0P8OY) ... to attend public or private school. SB277 cleared three ... the Appropriations Committee (Sacramento Bee, May 11, 2015, bit.ly/1Gh9jU7). ... , “We believe that this bill affects the ... than it will (the) affect public health of California.. ...
Breaking Medicine News(10 mins):Health News:New Study from RSSearch® Patient Registry Highlights Treatment Patterns and Clinical Outcomes of Stereotactic Radiosurgery for Central Lung Tumors 2Health News:New Study from RSSearch® Patient Registry Highlights Treatment Patterns and Clinical Outcomes of Stereotactic Radiosurgery for Central Lung Tumors 3Health News:Early Single Sport Specialization May Put Youth Athletes at Risk for Overuse Injuries According to Colorado Knee Specialist Robert LaPrade, MD, PhD 2Health News:Early Single Sport Specialization May Put Youth Athletes at Risk for Overuse Injuries According to Colorado Knee Specialist Robert LaPrade, MD, PhD 3Health News:Scalisi Skincare Wins Coveted CEW QVC Beauty Quest Award for Innovative and Patented Formulation 2Health News:A Voice For Choice Releases A Statement As SB277 Is Referred To Single Assembly Committee And Bypasses Education and Judicial Scrutiny 2
... By Amanda Gardner HealthDay Reporter , TUESDAY, ... belly fat of 10 heart attack patients managed to improve ... is the first time this type of therapy has been ... Tuesday at the American Heart Association,s annual meeting in Chicago. ...
... Steven Reinberg HealthDay Reporter , TUESDAY, Nov. ... advisers were weighing Tuesday whether to recommend the first ... the autoimmune disease lupus. The drug, belimumab (Benlysta), ... treat patients who suffer from systemic lupus erythematosus. ...
... study from the Swedish medical university Karolinska Institutet shows ... aneurysm. These drugs, which block cysteinyl-leukotrienes, could reduce the ... of the aortic wall, and thus the risk of ... the need for complicated and risky surgery. The results ...
... MONDAY, Nov. 15 (HealthDay News) -- It rarely happens, ... and sponges are left inside children undergoing surgery, according to ... mishaps were not more likely to die, but the errors ... long and cost more than double that of the average ...
... The risk of radiation-induced breast cancer from mammography screening ... saved, according to a new study appearing online and in ... "Recently, there have been reports in the press focusing on ... periodic screening," said the study,s lead author, Martin J. Yaffe, ...
... factor 7 (rFVIIa) a drug used to treat ... not recommended because of the potential for adverse events, ... Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj100408.pdf. Recombinant activated factor ... of bleeding in hemophilia patients. It is also used ...
Cached Medicine News:Health News:Study Hints at Stem Cells From Belly Fat as Treatment for Heart Attack 2Health News:Study Hints at Stem Cells From Belly Fat as Treatment for Heart Attack 3Health News:FDA Advisers Consider New Lupus Drug 2Health News:Aortic aneurysm treatable with asthma drugs 2Health News:Sponges, Surgical Tools Sometimes Left in Kids After Operation 2Health News:Sponges, Surgical Tools Sometimes Left in Kids After Operation 3Health News:Radiation fears should not deter women from mammography screening 2Health News:Hemostatic drug less effective than originally predicted 2
(Date:6/1/2015)... DUBLIN , June 1, 2015 /PRNewswire/ ... http://www.researchandmarkets.com/research/qrmgrq/_analysis_of_the ) has announced the addition of ... Image Displays Market" report to their ... ,This report provides an in-depth analysis of ... revenue forecast, market shares, market dynamics, and ...
(Date:6/1/2015)... -- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK ) today announced data ... in a Phase 1 investigator-sponsored study at the University ... presented at the 2015 American Society of Clinical Oncology ... Results from this study show a tolerable safety ... given intravenously.  Based in part on the ...
(Date:6/1/2015)... June 1, 2015 The Middle Eastern MRI systems ... which is replacing CT because of its higher sensitivity and ... one between the two available systems of MRI, open and ... top and bottom and do not enclose the patient in ... a study which shows that one in every 6 patients ...
Breaking Medicine Technology:Analysis of the US Medical Image Displays Market 2015-2017 2Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 2Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 3Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 4Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 5Middle East Open System MRI Market - Growth, Trends And Forecasts (2014 - 2019) 2
... the,symptoms of thyroid disease for another disorder such ... a new edition of a report from,Harvard Medical ... particularly in older men and women, that doctors ... focus on common,illnesses that occur with age, according ...
... /Xinhua-PRNewswire/ -- TaiGen Biotechnology,Inc. announces the successful completion ... clinical trial of Nemonoxacin (TG-873870) for,the treatment of ... have been admitted to the trial. Completion of ... quarter of 2007. In this trial, the effect,of ...
Cached Medicine Technology:You May Have a Thyroid Problem and Not Know It - Particularly If You're Over 60, Says a New Harvard Medical School Report 2TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP) 2
All Keeler otoscopes have bright halogen illumination for clear and accurate visualization of aural canal. Lithium-ion batteries with quick recharge capability. Ring rheostat for fine control of il...
Pocket-sized instrument. All Keeler otoscopes have bright halogen illumination for clear and accurate visualization of aural canal. Lithium-ion batteries with quick recharge capability. Ring rheos...
Pocket-sized instrument with fiber optic illumination. Swivelling viewing window with 3X magnification....
All metal construction with fiber optic illumination. Large diameter viewing port, insufflation port, and swivelling airtight window....
Medicine Products: